PharmGKB Blog
Wednesday, May 12, 2021

Expanded Pharmacokinetics Pathways for PPIs

›
The Proton Pump Inhibitor Pathway, Pharmacokinetics has been updated and expanded to now highlight four pathways with candidate genes and dr...
Monday, May 10, 2021

CPIC seeks feedback for MT-RNR1 terminology

›
We announced last December that the Clinical Pharmacogenetics Implementation Consortium ( CPIC )  was launching its Term Standardization Ph...
Thursday, May 6, 2021

Rollout of genotype picker tool on DPWG guideline annotations

›
The allele pull-down menu (also known as the genotype-picker tool) on PharmGKB annotations of CPIC guidelines is an extremely popular featur...
Tuesday, May 4, 2021

CYP3A4 now available in PharmVar

›
PharmVar and PharmGKB are excited to announce that   CYP3A4   has been transitioned into the PharmVar database. Check it out   here . Numero...
Thursday, March 25, 2021

PharmGKB introduces scoring system for variant and clinical annotations and updated Levels of Evidence

›
Since their introduction in 2010, clinical annotations have become one of the most popular features of PharmGKB. Each clinical annotation s...
Tuesday, March 23, 2021

Two new pathways released: Allopurinol Pharmacokinetics and Pimozide Pharmacokinetics.

›
Allopurinol is a purine analogue used in the treatment of gout. This drug has a level A CPIC Guideline for allopurinol and HLA-B . The new p...
Monday, March 1, 2021

Milestones in Payer Coverage Set to Expand Pharmacogenomic Testing

›
  A new perspective just out in   Genetics in Medicine   describes the improvements in the US payer landscape for pharmacogenomics test reim...
‹
›
Home
View web version

Contributors

  • Caroline Thorn, Curator
  • Katrin Sangkuhl
  • Li Gong
  • Mark Woon
  • Mark Woon
  • Michelle Whirl-Carrillo, Director and Co-PI
  • Ryan Whaley, Technical Lead
  • Teri Klein, Co-PI PharmGKB, CPIC, PharmCAT & ClinGen
Powered by Blogger.